The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of tough-to-treat solid tumors.

French pharmaceutical and healthcare company Sanofi has agreed to buy the British biotechnology firm Vicebio for up to $1.6bn ...

French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total ...

Sanofi agreed to buy UK vaccine developer Vicebio Ltd. for as much as $1.6 billion, as it seeks to expand in respiratory ...

Small-caps stocks may benefit soon from deglobalization, increased defense spending and a new era of tech advancement.

Jyong Biotech Ltd., a Taiwan-based biotechnology company focused on developing innovative plant-derived drugs for urinary system diseases, announced the closing of its initial public offering (IPO ...

New Taipei City, Taiwan, June 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and ...

About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance.

TEL AVIV, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a ...

HAPPY SOUL BIOTECH PRIVATE LIMITED is a company registered in India on 06-02-2025 & Corporate Identification Number (CIN) is U56290DL2025PTC442261. HAPPY SOUL BIOTECH PRIVATE LIMITED's registered ...